Situace v diagnostice a léčbě ischemické choroby dolních končetin v České republice
_{(poznatky z projektu MOET ICHDK – Monitoring Efektivní Terapie ICHDK)}

Czech version

Authors: D. Karetová; J. Vojtíšková; K. Roztočil; B. Seifert
Published in: Kardiol Rev Int Med 2010, 12(4): 181-186
Category: Angiological Symposium

Overview

The MOET ICHDK (Monitoring of an Effective Therapy of Peripheral Arterial Disease, MOET PAD) project had established collaboration between general practitioners and angiologists in the area of PAD – both symptomatic and asymptomatic – across the Czech Republic and emphasised the need for comprehensive care for patients with PAD with respect to atherosclerosis risk factors interventions in primary care. Twelve-month monitoring and treatment intensification led to important decrease in total cholesterol, LDL-cholesterol, triacylglycerols levels and increased the number of patients with hypertension who achieved target values. The number of smokers in the evaluated cohort decreased, while body weight did not decline.

Keywords:
peripheral arterial disease – early diagnosis – measurement of ischemic index – risk factor intervention

Sources

1. Norgren L, Hiatt WR, Dormandy MR et al. TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45: S5A–S67A.

2. Hirsch AT, Haskal ZJ, Hertzer NR et al. CC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006; 47: 1239–1312.

3. Hirsch AT, Criqui MH, Treat-Jacobson D et al. Peripheral arterial disease detection awareness, and treatment in primary care. JAMA 2001; 286: 1317–1324.

4. Blacher J, Cacoub P, Luizy F et al. Peripheral arterial disease versus other localizations of vascular disease: The ATTEST study. J Vasc Surg 2006; 44: 314–318.

5. Welten GM, Schouten O, Hoeks SE et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol 2008; 51: 1588–1596.

6. McDermott MM, Guralnik JM, Ferucci L et al. Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation 2008; 117: 2484–2491.

7. Diehm C, Schuster A, Allenberg et al. High prevalence of peripheral arterial disease and comorbidity in 6 880 primary care patients: cross sectional study. Atherosclerosis 2004; 172: 95–105.

8. Diehm C, Allenberg JR, Pittrow D et al. German Epidemiological Trial on Ankle Brachial Index Study Group. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009; 120: 2053–2061.

9. Holland-Letz T, Endres HG, Biedermann S et al. Reproducibility and reliability of the Antle-brachial index as assessed by vascular experts, family physicians and nurses. Vasc Med 2007; 12: 105–112.

10. Karetová D, Vojtíšková J, Ingrischová M. MOET – Projekt časné detekce ischemické choroby dolních končetin a její efektivní terapie. Practicus 2008; 7: 10–14.

11. Karetová D, Vojtíšková J, Ingrischová M. Zpráva o projektu MOET ICHDK – dílčí výsledky (podzim 2009). Practicus 2009; 8: 28–30.

12. Roztočil K, Karetová D, Vojtíšková J. Projekt MOET v České republice. Edukace angiologů i praktických lékařů v problematice ICHDK. Medical Tribune 2009; 14: C4–C4.